DK1553927T3 - Gel-stabiliserede, nanopartikulære aktivstof-sammensætninger - Google Patents
Gel-stabiliserede, nanopartikulære aktivstof-sammensætningerInfo
- Publication number
- DK1553927T3 DK1553927T3 DK03816299.6T DK03816299T DK1553927T3 DK 1553927 T3 DK1553927 T3 DK 1553927T3 DK 03816299 T DK03816299 T DK 03816299T DK 1553927 T3 DK1553927 T3 DK 1553927T3
- Authority
- DK
- Denmark
- Prior art keywords
- active agent
- solid
- dosage form
- gel
- stabilized
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000002105 nanoparticle Substances 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 4
- 239000007787 solid Substances 0.000 abstract 4
- 239000002552 dosage form Substances 0.000 abstract 3
- 108010010803 Gelatin Proteins 0.000 abstract 2
- 239000008273 gelatin Substances 0.000 abstract 2
- 229920000159 gelatin Polymers 0.000 abstract 2
- 235000019322 gelatine Nutrition 0.000 abstract 2
- 235000011852 gelatine desserts Nutrition 0.000 abstract 2
- 238000004090 dissolution Methods 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- 238000001879 gelation Methods 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Yarns And Mechanical Finishing Of Yarns Or Ropes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40958702P | 2002-09-11 | 2002-09-11 | |
| PCT/US2003/028380 WO2005000265A2 (en) | 2002-09-11 | 2003-09-11 | Gel-stabilized nanoparticulate active agent compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1553927T3 true DK1553927T3 (da) | 2011-01-31 |
Family
ID=33551184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03816299.6T DK1553927T3 (da) | 2002-09-11 | 2003-09-11 | Gel-stabiliserede, nanopartikulære aktivstof-sammensætninger |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7713551B2 (da) |
| EP (1) | EP1553927B9 (da) |
| JP (1) | JP4878839B2 (da) |
| AT (1) | ATE487470T1 (da) |
| AU (1) | AU2003304237A1 (da) |
| CA (1) | CA2498207C (da) |
| CY (1) | CY1110949T1 (da) |
| DE (1) | DE60334924D1 (da) |
| DK (1) | DK1553927T3 (da) |
| ES (1) | ES2355723T3 (da) |
| PT (1) | PT1553927E (da) |
| SI (1) | SI1553927T1 (da) |
| WO (1) | WO2005000265A2 (da) |
Families Citing this family (107)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK287674B6 (sk) * | 1998-11-02 | 2011-05-06 | Elan Pharma International Limited | Mnohočasticový prostriedok s modifikovaným uvoľňovaním obsahujúci metylfenidát, pevná orálne dávková forma s jeho obsahom a jeho použitie |
| US20080102121A1 (en) * | 1998-11-02 | 2008-05-01 | Elan Pharma International Limited | Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone |
| US20080113025A1 (en) * | 1998-11-02 | 2008-05-15 | Elan Pharma International Limited | Compositions comprising nanoparticulate naproxen and controlled release hydrocodone |
| US7364752B1 (en) | 1999-11-12 | 2008-04-29 | Abbott Laboratories | Solid dispersion pharamaceutical formulations |
| ATE329579T1 (de) * | 1999-11-12 | 2006-07-15 | Abbott Lab | Feste dispersion mit ritonavir, fenofibrat oder griseofulvin |
| US20030206958A1 (en) * | 2000-12-22 | 2003-11-06 | Cattaneo Maurizio V. | Chitosan biopolymer for the topical delivery of active agents |
| US7758890B2 (en) * | 2001-06-23 | 2010-07-20 | Lyotropic Therapeutics, Inc. | Treatment using dantrolene |
| US7923431B2 (en) | 2001-12-21 | 2011-04-12 | Ferrosan Medical Devices A/S | Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
| JP4598399B2 (ja) * | 2002-02-04 | 2010-12-15 | エラン ファーマ インターナショナル，リミティド | 表面安定剤としてリゾチームを有するナノ粒子組成物 |
| EP1559433A4 (en) * | 2002-10-22 | 2009-11-04 | Dainippon Sumitomo Pharma Co | STABILIZED COMPOSITION |
| WO2004053051A2 (en) * | 2002-12-11 | 2004-06-24 | Ferrosan A/S | Gelatine-based materials as swabs |
| DE602004012403T2 (de) | 2003-04-29 | 2009-03-19 | Orexigen Therapeutics, Inc., La Jolla | Zusammensetzungen zur beeinflussung des gewichtsverlusts |
| US8377952B2 (en) * | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
| US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
| CA2554994C (en) * | 2004-01-30 | 2015-05-19 | Ferrosan A/S | Haemostatic sprays and compositions |
| CA2565236A1 (en) * | 2004-05-06 | 2005-11-17 | Ivrea Pharmaceuticals, Inc. | Particles for the delivery of active agents |
| WO2006005340A1 (en) * | 2004-07-09 | 2006-01-19 | Ferrosan A/S | Haemostatic composition comprising hyaluronic acid |
| DE102004041340A1 (de) * | 2004-08-20 | 2006-02-23 | Deutsche Gelatine-Fabriken Stoess Ag | Nanopartikel und Verfahren zu deren Herstellung |
| UA89513C2 (uk) * | 2004-12-03 | 2010-02-10 | Элан Фарма Интернешнл Лтд. | Стабільна композиція з наночастинок ралоксифену гідрохлориду |
| CN101189001A (zh) * | 2005-02-15 | 2008-05-28 | 伊兰制药国际有限公司 | 纳米微粒苯并二氮杂䓬气雾剂及注射剂 |
| US20080254114A1 (en) * | 2005-03-03 | 2008-10-16 | Elan Corporation Plc | Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles |
| KR20080008403A (ko) * | 2005-05-10 | 2008-01-23 | 엘란 파마 인터내셔널 리미티드 | 나노입자형 클로피도그렐 제제 |
| WO2006132752A1 (en) * | 2005-05-10 | 2006-12-14 | Elan Pharma International Limited | Nanoparticulate and controlled release compositions comprising vitamin k2 |
| US20100028439A1 (en) * | 2005-05-23 | 2010-02-04 | Elan Pharma International Limited | Nanoparticulate stabilized anti-hypertensive compositions |
| WO2006133045A1 (en) * | 2005-06-03 | 2006-12-14 | Elan Pharma International, Limited | Nanoparticulate benidipine compositions |
| US20060292214A1 (en) * | 2005-06-03 | 2006-12-28 | Elan Pharma International Limited | Nanoparticulate acetaminophen formulations |
| WO2006133046A2 (en) * | 2005-06-03 | 2006-12-14 | Elan Pharma International, Limited | Nanoparticulate imatinib mesylate formulations |
| WO2008073068A1 (en) | 2005-06-08 | 2008-06-19 | Elan Pharma International Limited | Nanoparticulate and controlled release compositions comprising cefditoren |
| US20100136106A1 (en) * | 2005-06-08 | 2010-06-03 | Gary Liversidge | Modified Release Famciclovir Compositions |
| US20070059371A1 (en) * | 2005-06-09 | 2007-03-15 | Elan Pharma International, Limited | Nanoparticulate ebastine formulations |
| US20070003615A1 (en) * | 2005-06-13 | 2007-01-04 | Elan Pharma International Limited | Nanoparticulate clopidogrel and aspirin combination formulations |
| JP2008543862A (ja) * | 2005-06-15 | 2008-12-04 | エラン ファーマ インターナショナル リミテッド | ナノ粒子アゼルニジピン製剤 |
| US9119899B2 (en) * | 2006-01-18 | 2015-09-01 | Cormatrix Cardiovascular, Inc. | Method and system for treatment of cardiovascular disorders |
| JP2009507925A (ja) * | 2005-09-13 | 2009-02-26 | エラン ファーマ インターナショナル リミテッド | ナノ粒子タダラフィル製剤 |
| EP2279727A3 (en) | 2005-09-15 | 2011-10-05 | Elan Pharma International Limited | Nanoparticulate aripiprazole formulations |
| PT2135603E (pt) | 2005-11-22 | 2013-04-03 | Orexigen Therapeutics Inc | Composições e métodos para aumentar a sensibilidade à insulina |
| DK1954241T3 (da) * | 2005-11-28 | 2012-06-18 | Orexigen Therapeutics Inc | Zonisamid-formulering med vedvarende frigivelse |
| CA2631233C (en) | 2005-11-28 | 2011-11-08 | Marinus Pharmaceuticals | Ganaxolone formulations and methods for the making and use thereof |
| WO2007066147A1 (en) * | 2005-12-07 | 2007-06-14 | Pharmakodex Ltd | Topical compositions for paediatric use |
| EP1984344B1 (en) | 2005-12-29 | 2012-09-26 | Lexicon Pharmaceuticals, Inc. | Multicyclic amino acid derivatives and methods of their use |
| US7649098B2 (en) | 2006-02-24 | 2010-01-19 | Lexicon Pharmaceuticals, Inc. | Imidazole-based compounds, compositions comprising them and methods of their use |
| US8187659B2 (en) | 2006-05-02 | 2012-05-29 | Jerry Robertson Real Estate Llc | Solid medicament dosage form consumption aid |
| US8287929B2 (en) * | 2006-05-26 | 2012-10-16 | Cruz Serrano Jose Antonio | Protein gelatinous food and its manufacture process |
| SG170047A1 (en) | 2006-05-30 | 2011-04-29 | Elan Pharma Int Ltd | Nanoparticulate posaconazole formulations |
| US8916195B2 (en) * | 2006-06-05 | 2014-12-23 | Orexigen Therapeutics, Inc. | Sustained release formulation of naltrexone |
| CA2660649A1 (en) * | 2006-06-23 | 2007-12-27 | Elan Pharma International Limited | Compositions comprising nanoparticulate naproxen and controlled release hydrocodone |
| JP2009543797A (ja) * | 2006-07-10 | 2009-12-10 | エラン ファーマ インターナショナル，リミティド | ナノ粒子ソラフェニブ製剤 |
| KR100809903B1 (ko) | 2006-09-05 | 2008-03-06 | 주식회사유한양행 | 안정화된 클로피도그렐-함유 입자, 그의 제조방법, 및 이를포함하는 약학 조성물 |
| CA2668884C (en) | 2006-11-09 | 2016-11-01 | Orexigen Therapeutics, Inc. | Layered pharmaceutical formulations |
| KR20150082689A (ko) * | 2006-11-09 | 2015-07-15 | 오렉시젠 세러퓨틱스 인크. | 단위 용량 팩키지 |
| KR20090091321A (ko) | 2006-11-28 | 2009-08-27 | 마리누스 파마슈티컬스 | 나노입자 제형, 이의 제조방법 및 이의 용도 |
| UA99270C2 (en) | 2006-12-12 | 2012-08-10 | Лексикон Фармасьютикалз, Инк. | 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use |
| US20080226734A1 (en) * | 2007-03-16 | 2008-09-18 | Elan Corporation Plc | Combination of a narcotic and non-narcotic analgesic |
| KR100761040B1 (ko) | 2007-03-22 | 2007-10-04 | 현대약품 주식회사 | 산 불안정성 벤즈이미다졸계 화합물을 포함하는 약학조성물 |
| KR100761041B1 (ko) | 2007-03-22 | 2007-10-04 | 현대약품 주식회사 | 산 불안정성 벤즈이미다졸계 화합물을 포함하는 약학조성물 |
| CA2688736C (en) * | 2007-04-10 | 2017-07-04 | Saint Simeon Lda | Novel compositions containing lysozyme and c-1/c-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology |
| JP4941977B2 (ja) * | 2007-04-11 | 2012-05-30 | 大蔵製薬株式会社 | ベンズイソキサゾール誘導体の経口ゼリー状医薬組成物 |
| US10092524B2 (en) | 2008-06-11 | 2018-10-09 | Edge Therapeutics, Inc. | Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage |
| PT103765A (pt) * | 2007-06-20 | 2008-12-22 | Inst Superior Tecnico | Síntese e aplicação de uma família de novos materiais resultantes do cruzamento entre gelatina e sais orgânicos |
| US20090149954A1 (en) * | 2007-12-07 | 2009-06-11 | Xianbo Hu | Bone substitute |
| US20090155363A1 (en) * | 2007-12-14 | 2009-06-18 | Todd Maibach | Methods for oral administration of active drugs |
| WO2009109194A2 (en) * | 2008-02-29 | 2009-09-11 | Ferrosan A/S | Device for promotion of hemostasis and/or wound healing |
| US8389012B2 (en) * | 2008-03-07 | 2013-03-05 | The Corporation Of Mercer University | Gellan-gum nanoparticles and methods of making and using the same |
| WO2009117401A2 (en) * | 2008-03-21 | 2009-09-24 | Elan Pharama International Limited | Compositions for site-specific delivery of imatinib and methods of use |
| US20110144145A1 (en) * | 2008-05-30 | 2011-06-16 | Orexigen Therapeutics, Inc. | Methods for treating visceral fat conditions |
| US9498440B2 (en) | 2009-05-22 | 2016-11-22 | Inventia Healthcare Private Limited | Extended release pharmaceutical compositions |
| ES2609415T3 (es) | 2009-05-27 | 2017-04-20 | Alkermes Pharma Ireland Limited | Reducción de agregación laminar en composiciones con nanopartículas de meloxicam |
| SG177281A1 (en) * | 2009-06-19 | 2012-02-28 | Nanoform Hungary Ltd | Nanostructured sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them |
| US9775819B2 (en) * | 2009-09-16 | 2017-10-03 | R.P. Scherer Technologies, Llc | Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin |
| CN102711749A (zh) | 2009-11-05 | 2012-10-03 | 莱西肯医药有限公司 | 用于癌症治疗的色氨酸羟化酶抑制剂 |
| ES2762113T3 (es) * | 2010-01-11 | 2020-05-22 | Nalpropion Pharmaceuticals Inc | Métodos de proporcionar terapia de pérdida de peso en pacientes con depresión mayor |
| JP2013519673A (ja) | 2010-02-10 | 2013-05-30 | レクシコン ファーマシューティカルズ インコーポレイテッド | 転移性骨疾患の治療のためのトリプトファンヒドロキシラーゼ阻害剤 |
| GB201006218D0 (en) | 2010-04-14 | 2010-06-02 | Ayanda As | Composition |
| WO2011146583A2 (en) | 2010-05-19 | 2011-11-24 | Elan Pharma International Limited | Nanoparticulate cinacalcet formulations |
| CN103209684A (zh) | 2010-09-13 | 2013-07-17 | 贝夫-厄克斯股份有限公司 | 包含异味掩蔽剂的含水药物递送系统 |
| US8691275B2 (en) | 2011-01-28 | 2014-04-08 | Zx Pharma, Llc | Controlled-release melatonin compositions and related methods |
| US9532952B2 (en) | 2011-01-28 | 2017-01-03 | Physician's Seal, LLC | Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients |
| GB2501664B (en) * | 2011-02-11 | 2017-09-27 | Edge Therapeutics Inc | Compositions and methods for improving prognosis of a human with subarachnoid hemorrhage |
| JP6336899B2 (ja) | 2011-04-05 | 2018-06-06 | エッジ セラピューティクス インコーポレイテッド | 脳血流に影響する脳損傷後の結果を改善するための脳室内ドラッグデリバリーシステム |
| CA2833105C (en) * | 2011-04-11 | 2019-04-23 | Ayanda Group As | Oral pharmaceutical dispersion compositions |
| EP2540287A1 (en) | 2011-07-01 | 2013-01-02 | FutureChemistry | Continuous flow production of gelatin nanoparticles |
| JP5991978B2 (ja) * | 2011-09-09 | 2016-09-14 | 東洋カプセル株式会社 | カンデサルタンシレキセチル含有医薬組成物 |
| RU2657955C2 (ru) | 2012-03-06 | 2018-06-18 | Ферросан Медикал Дивайсиз А/С | Контейнер под давлением, содержащий гемостатическую пасту |
| US9452135B2 (en) | 2012-03-20 | 2016-09-27 | Particle Dynamics International, Llc | Gelling agent-based dosage form |
| US20130303763A1 (en) | 2012-03-30 | 2013-11-14 | Michael D. Gershon | Methods and compositions for the treatment of necrotizing enterocolitis |
| KR20200035501A (ko) | 2012-06-06 | 2020-04-03 | 오렉시젠 세러퓨틱스 인크. | 과체중 및 비만의 치료 방법 |
| BR112014030962A2 (pt) | 2012-06-12 | 2017-06-27 | Ferrosan Medical Devices As | métodos para preparação e para reconstituição de uma composição seca adequada para uso em hemostase e cicatrização de feridas, e, kit hemostático |
| FR2999086B1 (fr) * | 2012-12-10 | 2015-04-10 | Ethypharm Sa | Composition orale et/ou buccale sous forme de film fin d'un principe actif faiblement soluble, son procede de preparation et son utilisation |
| WO2014202760A2 (en) | 2013-06-21 | 2014-12-24 | Ferrosan Medical Devices A/S | Vacuum expanded dry composition and syringe for retaining same |
| EP3082428A4 (en) | 2013-12-09 | 2017-08-02 | Respira Therapeutics, Inc. | Pde5 inhibitor powder formulations and methods relating thereto |
| BR112016013322B1 (pt) | 2013-12-11 | 2020-07-21 | Ferrosan Medical Devices A/S | métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit |
| RU2715235C2 (ru) | 2014-10-13 | 2020-02-26 | Ферросан Медикал Дивайсиз А/С | Сухая композиция для использования при гемостазе и заживлении ран |
| US10653837B2 (en) | 2014-12-24 | 2020-05-19 | Ferrosan Medical Devices A/S | Syringe for retaining and mixing first and second substances |
| KR20160081646A (ko) * | 2014-12-31 | 2016-07-08 | 건일제약 주식회사 | 멜라토닌 및 설트랄린을 포함하는 경구용 복합정제 |
| CN105981748B (zh) * | 2015-05-07 | 2018-12-04 | 博约生物科技(苏州)有限公司 | 一种提取天然抑菌剂有效成分的方法 |
| AU2016290433B2 (en) | 2015-07-03 | 2018-05-24 | Ferrosan Medical Devices A/S | Syringe for mixing two components and for retaining a vacuum in a storage condition |
| MX2018004376A (es) | 2015-10-16 | 2018-08-01 | Marinus Pharmaceuticals Inc | Formulaciones inyectables de neuroesteroides que contienen nanoparticulas. |
| US20180042903A1 (en) | 2016-08-11 | 2018-02-15 | Ovid Therapeutics Inc. | Methods and compositions for treatment of epileptic disorders |
| US10391105B2 (en) | 2016-09-09 | 2019-08-27 | Marinus Pharmaceuticals Inc. | Methods of treating certain depressive disorders and delirium tremens |
| WO2019072877A1 (en) | 2017-10-10 | 2019-04-18 | Capsugel Belgium Nv | GETTING MULTIPARTICULAR COMPOSITIONS |
| AU2019266529B2 (en) | 2018-05-09 | 2024-05-23 | Ethicon Inc. | Method for preparing a haemostatic composition |
| WO2020118142A1 (en) | 2018-12-07 | 2020-06-11 | Marinus Pharmaceuticals, Inc. | Ganaxolone for use in prophylaxis and treatment of pospartum depression |
| WO2021026124A1 (en) | 2019-08-05 | 2021-02-11 | Marinus Pharmaceuticals, Inc. | Ganaxolone for use in treatment of status epilepticus |
| MX2022006014A (es) | 2019-12-06 | 2022-06-22 | Marinus Pharmaceuticals Inc | Ganaxolona para uso en el tratamiento del complejo de esclerosis tuberosa. |
| US11071739B1 (en) | 2020-09-29 | 2021-07-27 | Genus Lifesciences Inc. | Oral liquid compositions including chlorpromazine |
| EP4122453A1 (en) * | 2021-07-22 | 2023-01-25 | Universität Heidelberg | Thermoreversible gelatin matrix for stability enhancement and ready-to-use liquid application of nanoparticles and colloidal drugs |
| CN117186267B (zh) * | 2022-05-31 | 2025-01-28 | 杭州协合医疗用品有限公司 | 一种羟丁基甲壳素、羟丁基甲壳素水凝胶及制备方法 |
Family Cites Families (89)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4003999A (en) * | 1972-10-25 | 1977-01-18 | A. H. Robins Company, Incorporated | Aspirin-tea coprecipitates for treating inflammation |
| US4486412A (en) | 1983-03-15 | 1984-12-04 | Pharmacaps, Inc. | Encapsulated antacid dispersions |
| US4826689A (en) | 1984-05-21 | 1989-05-02 | University Of Rochester | Method for making uniformly sized particles from water-insoluble organic compounds |
| US4783484A (en) | 1984-10-05 | 1988-11-08 | University Of Rochester | Particulate composition and use thereof as antimicrobial agent |
| US4778676A (en) * | 1985-12-20 | 1988-10-18 | Warner-Lambert Company | Confectionery delivery system for actives |
| US4882157A (en) * | 1985-12-20 | 1989-11-21 | Yang Robert K | Confectionery delivery system for anti-cholesterolemics |
| US4795642A (en) | 1986-05-01 | 1989-01-03 | Pharmacaps, Inc. | Gelatin-encapsulated controlled-release composition |
| US4708834A (en) | 1986-05-01 | 1987-11-24 | Pharmacaps, Inc. | Preparation of gelatin-encapsulated controlled release composition |
| US4837255A (en) * | 1987-03-10 | 1989-06-06 | Ciba-Geigy Corporation | Palatable hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin |
| US4935243A (en) | 1988-12-19 | 1990-06-19 | Pharmacaps, Inc. | Chewable, edible soft gelatin capsule |
| US6482516B1 (en) | 1993-07-20 | 2002-11-19 | Banner Pharmacaps, Inc. | Enrobed tablet |
| US5146730A (en) | 1989-09-20 | 1992-09-15 | Banner Gelatin Products Corp. | Film-enrobed unitary-core medicament and the like |
| AU642066B2 (en) | 1991-01-25 | 1993-10-07 | Nanosystems L.L.C. | X-ray contrast compositions useful in medical imaging |
| US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| US5552160A (en) | 1991-01-25 | 1996-09-03 | Nanosystems L.L.C. | Surface modified NSAID nanoparticles |
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| WO1993000933A1 (en) | 1991-07-05 | 1993-01-21 | University Of Rochester | Ultrasmall non-aggregated porous particles entrapping gas-bubbles |
| US5200191A (en) | 1991-09-11 | 1993-04-06 | Banner Gelatin Products Corp. | Softgel manufacturing process |
| EP0615445B1 (de) | 1991-12-05 | 1996-05-15 | ALFATEC-PHARMA GmbH | Pharmazeutisch applizierbares nanosol und verfahren zu seiner herstellung |
| DE4140179C2 (de) | 1991-12-05 | 1995-12-21 | Alfatec Pharma Gmbh | Akutform für ein Ibuprofen enthaltendes Arzneimittel |
| AU660852B2 (en) | 1992-11-25 | 1995-07-06 | Elan Pharma International Limited | Method of grinding pharmaceutical substances |
| US5349957A (en) | 1992-12-02 | 1994-09-27 | Sterling Winthrop Inc. | Preparation and magnetic properties of very small magnetite-dextran particles |
| US5298262A (en) | 1992-12-04 | 1994-03-29 | Sterling Winthrop Inc. | Use of ionic cloud point modifiers to prevent particle aggregation during sterilization |
| US5346702A (en) | 1992-12-04 | 1994-09-13 | Sterling Winthrop Inc. | Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization |
| US5302401A (en) | 1992-12-09 | 1994-04-12 | Sterling Winthrop Inc. | Method to reduce particle size growth during lyophilization |
| US5340564A (en) | 1992-12-10 | 1994-08-23 | Sterling Winthrop Inc. | Formulations comprising olin 10-G to prevent particle aggregation and increase stability |
| US5336507A (en) | 1992-12-11 | 1994-08-09 | Sterling Winthrop Inc. | Use of charged phospholipids to reduce nanoparticle aggregation |
| US5429824A (en) | 1992-12-15 | 1995-07-04 | Eastman Kodak Company | Use of tyloxapole as a nanoparticle stabilizer and dispersant |
| US5352459A (en) | 1992-12-16 | 1994-10-04 | Sterling Winthrop Inc. | Use of purified surface modifiers to prevent particle aggregation during sterilization |
| US5326552A (en) | 1992-12-17 | 1994-07-05 | Sterling Winthrop Inc. | Formulations for nanoparticulate x-ray blood pool contrast agents using high molecular weight nonionic surfactants |
| US5401492A (en) | 1992-12-17 | 1995-03-28 | Sterling Winthrop, Inc. | Water insoluble non-magnetic manganese particles as magnetic resonance contract enhancement agents |
| US5264610A (en) | 1993-03-29 | 1993-11-23 | Sterling Winthrop Inc. | Iodinated aromatic propanedioates |
| TW384224B (en) | 1994-05-25 | 2000-03-11 | Nano Sys Llc | Method of preparing submicron particles of a therapeutic or diagnostic agent |
| US5718388A (en) | 1994-05-25 | 1998-02-17 | Eastman Kodak | Continuous method of grinding pharmaceutical substances |
| US5525328A (en) | 1994-06-24 | 1996-06-11 | Nanosystems L.L.C. | Nanoparticulate diagnostic diatrizoxy ester X-ray contrast agents for blood pool and lymphatic system imaging |
| US5587143A (en) | 1994-06-28 | 1996-12-24 | Nanosystems L.L.C. | Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanoparticle compositions |
| NZ280610A (en) * | 1994-12-29 | 1997-08-22 | Mcneil Ppc Inc | Soft gelatin-like pharmaceutical carrier: gelled polyethylene glycol and dispersed active agent |
| US5628981A (en) | 1994-12-30 | 1997-05-13 | Nano Systems L.L.C. | Formulations of oral gastrointestinal diagnostic x-ray contrast agents and oral gastrointestinal therapeutic agents |
| US5466440A (en) | 1994-12-30 | 1995-11-14 | Eastman Kodak Company | Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays |
| US5585108A (en) | 1994-12-30 | 1996-12-17 | Nanosystems L.L.C. | Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays |
| US5569448A (en) | 1995-01-24 | 1996-10-29 | Nano Systems L.L.C. | Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions |
| US5560931A (en) | 1995-02-14 | 1996-10-01 | Nawosystems L.L.C. | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
| US5571536A (en) | 1995-02-06 | 1996-11-05 | Nano Systems L.L.C. | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
| US5518738A (en) | 1995-02-09 | 1996-05-21 | Nanosystem L.L.C. | Nanoparticulate nsaid compositions |
| US5622938A (en) | 1995-02-09 | 1997-04-22 | Nano Systems L.L.C. | Sugar base surfactant for nanocrystals |
| US5593657A (en) | 1995-02-09 | 1997-01-14 | Nanosystems L.L.C. | Barium salt formulations stabilized by non-ionic and anionic stabilizers |
| US5534270A (en) | 1995-02-09 | 1996-07-09 | Nanosystems Llc | Method of preparing stable drug nanoparticles |
| US5591456A (en) | 1995-02-10 | 1997-01-07 | Nanosystems L.L.C. | Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer |
| US5500204A (en) | 1995-02-10 | 1996-03-19 | Eastman Kodak Company | Nanoparticulate diagnostic dimers as x-ray contrast agents for blood pool and lymphatic system imaging |
| US5573783A (en) | 1995-02-13 | 1996-11-12 | Nano Systems L.L.C. | Redispersible nanoparticulate film matrices with protective overcoats |
| US5510118A (en) | 1995-02-14 | 1996-04-23 | Nanosystems Llc | Process for preparing therapeutic compositions containing nanoparticles |
| US5543133A (en) | 1995-02-14 | 1996-08-06 | Nanosystems L.L.C. | Process of preparing x-ray contrast compositions containing nanoparticles |
| US5580579A (en) | 1995-02-15 | 1996-12-03 | Nano Systems L.L.C. | Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers |
| US5718919A (en) | 1995-02-24 | 1998-02-17 | Nanosystems L.L.C. | Nanoparticles containing the R(-)enantiomer of ibuprofen |
| US5565188A (en) | 1995-02-24 | 1996-10-15 | Nanosystems L.L.C. | Polyalkylene block copolymers as surface modifiers for nanoparticles |
| CA2213638C (en) | 1995-02-24 | 2004-05-04 | Nanosystems L.L.C. | Aerosols containing nanoparticle dispersions |
| US5573749A (en) | 1995-03-09 | 1996-11-12 | Nano Systems L.L.C. | Nanoparticulate diagnostic mixed carboxylic anhydrides as X-ray contrast agents for blood pool and lymphatic system imaging |
| US5643552A (en) | 1995-03-09 | 1997-07-01 | Nanosystems L.L.C. | Nanoparticulate diagnostic mixed carbonic anhydrides as x-ray contrast agents for blood pool and lymphatic system imaging |
| US5472683A (en) | 1995-03-09 | 1995-12-05 | Eastman Kodak Company | Nanoparticulate diagnostic mixed carbamic anhydrides as X-ray contrast agents for blood pool and lymphatic system imaging |
| US5521218A (en) | 1995-05-15 | 1996-05-28 | Nanosystems L.L.C. | Nanoparticulate iodipamide derivatives for use as x-ray contrast agents |
| US5573750A (en) | 1995-05-22 | 1996-11-12 | Nanosystems L.L.C. | Diagnostic imaging x-ray contrast agents |
| ATE212544T1 (de) | 1995-06-09 | 2002-02-15 | Scherer Technologies Inc R P | Weichgelatinekapsel mit teilchenmaterial |
| AU6921296A (en) * | 1995-09-19 | 1997-04-09 | Alcan International Limited | Precipitation-hardened aluminum alloys for automotive structural applications |
| US5834025A (en) | 1995-09-29 | 1998-11-10 | Nanosystems L.L.C. | Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions |
| US6045829A (en) | 1997-02-13 | 2000-04-04 | Elan Pharma International Limited | Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers |
| WO1998035666A1 (en) | 1997-02-13 | 1998-08-20 | Nanosystems Llc | Formulations of nanoparticle naproxen tablets |
| US6197787B1 (en) | 1997-03-03 | 2001-03-06 | Sanofi-Synthelabo | Pharmaceutical formulations containing poorly soluble drug substances |
| NL1009107C2 (nl) | 1997-11-12 | 1999-06-15 | Banner Pharmacaps Inc | Gelatine-uitspreidende doos met meervoudige, aanpasbare poortklep en meerlagig zacht gel. |
| US6432442B1 (en) * | 1998-02-23 | 2002-08-13 | Mcneil-Ppc, Inc. | Chewable product |
| US6153225A (en) | 1998-08-13 | 2000-11-28 | Elan Pharma International Limited | Injectable formulations of nanoparticulate naproxen |
| US6165506A (en) | 1998-09-04 | 2000-12-26 | Elan Pharma International Ltd. | Solid dose form of nanoparticulate naproxen |
| US8293277B2 (en) | 1998-10-01 | 2012-10-23 | Alkermes Pharma Ireland Limited | Controlled-release nanoparticulate compositions |
| AU6283299A (en) * | 1998-10-01 | 2000-04-17 | Elan Pharma International Limited | Controlled release nanoparticulate compositions |
| US6428814B1 (en) | 1999-10-08 | 2002-08-06 | Elan Pharma International Ltd. | Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| US6375986B1 (en) | 2000-09-21 | 2002-04-23 | Elan Pharma International Ltd. | Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate |
| US6270806B1 (en) | 1999-03-03 | 2001-08-07 | Elan Pharma International Limited | Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions |
| US6258380B1 (en) | 1999-03-05 | 2001-07-10 | Banner Pharmacaps, Inc. | Chewable soft capsule |
| US6267989B1 (en) | 1999-03-08 | 2001-07-31 | Klan Pharma International Ltd. | Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions |
| US6431478B1 (en) | 1999-06-01 | 2002-08-13 | Elan Pharma International Limited | Small-scale mill and method thereof |
| US6251426B1 (en) | 1999-09-02 | 2001-06-26 | Banner Pharmacaps, Inc. | Ibuprofen-containing softgels |
| DE60140947D1 (de) | 2000-04-26 | 2010-02-11 | Elan Pharma Int Ltd | Vorrichtung zur sanitären nassvermahlung |
| US6316029B1 (en) * | 2000-05-18 | 2001-11-13 | Flak Pharma International, Ltd. | Rapidly disintegrating solid oral dosage form |
| US6685961B1 (en) | 2000-10-24 | 2004-02-03 | Banner Pharmacaps, Inc. | Colored gelatin-based formulations and method |
| EP1392441B1 (en) | 2001-06-05 | 2008-07-23 | Elan Pharma International Limited | System and method for milling materials |
| US6949256B2 (en) | 2002-01-18 | 2005-09-27 | Banner Pharmacaps, Inc. | Non-gelatin capsule shell formulation |
| DE10244504A1 (de) | 2002-09-25 | 2004-04-08 | Capsulution Nanoscience Ag | Schnellfreisetzende Darreichungsform mit schwerlöslichem Wirkstoff |
| US20060088590A1 (en) | 2004-10-22 | 2006-04-27 | Banner Pharmacaps, Inc. | Non-blooming gelatin and non-gelatin formulations |
| JP5406530B2 (ja) | 2005-10-26 | 2014-02-05 | バナー ファーマキャプス， インコーポレイテッド | 親水性ベヒクルに基づく二重制御された放出マトリクスシステム |
| US20070148248A1 (en) | 2005-12-22 | 2007-06-28 | Banner Pharmacaps, Inc. | Gastric reflux resistant dosage forms |
-
2003
- 2003-09-11 SI SI200331901T patent/SI1553927T1/sl unknown
- 2003-09-11 EP EP03816299A patent/EP1553927B9/en not_active Expired - Lifetime
- 2003-09-11 JP JP2005503259A patent/JP4878839B2/ja not_active Expired - Fee Related
- 2003-09-11 PT PT03816299T patent/PT1553927E/pt unknown
- 2003-09-11 AU AU2003304237A patent/AU2003304237A1/en not_active Abandoned
- 2003-09-11 DK DK03816299.6T patent/DK1553927T3/da active
- 2003-09-11 DE DE60334924T patent/DE60334924D1/de not_active Expired - Lifetime
- 2003-09-11 WO PCT/US2003/028380 patent/WO2005000265A2/en active Application Filing
- 2003-09-11 AT AT03816299T patent/ATE487470T1/de active
- 2003-09-11 CA CA2498207A patent/CA2498207C/en not_active Expired - Fee Related
- 2003-09-11 ES ES03816299T patent/ES2355723T3/es not_active Expired - Lifetime
- 2003-09-11 US US10/659,706 patent/US7713551B2/en not_active Expired - Lifetime
-
2010
- 2010-11-26 CY CY20101101084T patent/CY1110949T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006514688A (ja) | 2006-05-11 |
| CA2498207C (en) | 2012-03-13 |
| JP4878839B2 (ja) | 2012-02-15 |
| US7713551B2 (en) | 2010-05-11 |
| CA2498207A1 (en) | 2005-01-06 |
| WO2005000265A2 (en) | 2005-01-06 |
| CY1110949T1 (el) | 2015-06-10 |
| ES2355723T3 (es) | 2011-03-30 |
| DE60334924D1 (de) | 2010-12-23 |
| AU2003304237A1 (en) | 2005-01-13 |
| PT1553927E (pt) | 2010-11-22 |
| WO2005000265A3 (en) | 2005-05-12 |
| AU2003304237A8 (en) | 2005-01-13 |
| EP1553927B1 (en) | 2010-11-10 |
| ATE487470T1 (de) | 2010-11-15 |
| EP1553927B9 (en) | 2011-09-21 |
| US20050031691A1 (en) | 2005-02-10 |
| SI1553927T1 (sl) | 2010-12-31 |
| EP1553927A2 (en) | 2005-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1553927T3 (da) | Gel-stabiliserede, nanopartikulære aktivstof-sammensætninger | |
| ATE381317T1 (de) | Nanopartikuläre zusammensetzungen in form festen darreichungen | |
| RS50025B (sr) | Farmaceutski preparati koji mogu da budu gelirani | |
| EP1781257A4 (en) | PHARMACEUTICAL FORMULATIONS WITH MICROPARTICLES OR NANOPARTICLES OF AN AGENT | |
| AR027091A1 (es) | Forma de dosificacion de farmacos accionada por un hidrogel | |
| BR0107869A (pt) | Composições farmacêuticas eletrogiradas | |
| DE60237449D1 (de) | Ammensetzungen und damit in beziehung stehende verwendungen | |
| BR0207930A (pt) | Composições farmacêuticas lìquidas com sabor mascarado | |
| DK1121103T3 (da) | Oralt disintegrerbare tabletter, der omfatter en benzimidazol | |
| AR049084A1 (es) | Composiciones de cuidado personal y concentrados para su elaboracion | |
| CO5170479A1 (es) | Emulsion aceite en agua que comprende un agente biologicamente activo micronizado y un sistema emulsionante adecuado saturado y un mono de ester de acido acrilico. . | |
| AR043272A1 (es) | Una microparticula recubierta con una sustancia lipofilica que contiene una droga proteica o antigeno y formulaciones que la comprenden | |
| DE60202794D1 (de) | Orodispersible tablette mit hoher homogenität und herstellungsverfahren dafür | |
| AR038947A1 (es) | Suspension oral de sabor agradable y metodo | |
| DE50007327D1 (de) | Antitranspirant-zusammensetzung enthaltend einen wasserlöslichen antitranspirant-wirkstoff | |
| IL154731A0 (en) | Ion-strength independent sustained release pharmaceutical formulation | |
| ATE348602T1 (de) | Nanoteilchen zur verabreichung von wirkstoffen, verfahren zur herstellung dieser teilchen und diese enthaltende zusammensetzung | |
| AR023138A1 (es) | Composicion para gomas de mascar medicadas, proceso de fabricacion y tabletas obtenidas con dicho proceso | |
| ME00568A (en) | Ciclesonide-containing aqueous pharmaceutical composition | |
| BR0206960A (pt) | Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose | |
| SE0001916D0 (sv) | Novel formulation | |
| DE60212088D1 (de) | Wasserfreie schweisshemende oder desodorierende zusammensetzungen enthaltend einen festen, wasserlöslichen hautpflegenden wirkstoff und glycerin | |
| MXPA05008921A (es) | Formulaciones orales semisolidas para liberacion inmediata que comprenden un agente hidrofobo anticancer, un glicerido poliglicolisado y un vehiculo hidrofilo. | |
| WO2004000223A3 (en) | Rapidly disintegrating formulations for treating or preventing mucositis | |
| BR0108732A (pt) | Composição farmacêutica para a prevenção e tratamento da progressão da fibrose e cirrose hepática, seu uso e método para a prevenção e tratamento da fibrose e cirrose hepática |